GEFTIGET

  • Favorite
GLS Pharma Ltd

Business Type:Manufacturer

Country/Region:India

Ddu Verified

HOT Rank

6/10

Product Information

  • Dosage Form:Tablet
  • Route of Administration:Oral
  • Shelf Life:2 years
  • Storage:Sealed
  • Qualification:FDA

Description

GEFTIGET

Gefitinib belongs to a new class of anti cancer drugs called tyrosine-kinase inhibitors which preferentially targets cancer cells unlike the older cancer chemotherapeutic drugs.

Gefitinib belongs to a new class of anti cancer drugs called tyrosine-kinase inhibitors which preferentially targets cancer cells unlike the older cancer chemotherapeutic drugs. Gefitinib has shown excellent results in a sub-group of lung cancer patients with EGFR mutation.

 

Indication:

  • As monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from gefitinib

Generic Name

Strength

Standard

Type

Packing

Pack Size

Gefitinib

250 mg

IP

Tab.

Bottle

 10s


You Might Also Like
Change a group
Inquiry Cart(0)